跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 89,602 条关于
“PH Health Limited”
全部
89,602
临床试验
66,537
药物
448
机构
2,838
资讯
19,779
3天前
FDA Approves DifGen's Generic Epinephrine Injection, Second Adrenalin Rival in US
去年
pH-D Feminine Health Initiates First FDA-Cleared Phase 3 Trial for Boric Acid Suppositories in Yeast Infections
2年前
Cannabidiol Shows Limited Impact on Quality of Life in HIV Patients with Controlled Viral Load
去年
Current Treatment Protocols for Ph+ ALL Treatment
去年
Foresee Pharmaceuticals Launches Phase 2 Trial of Mirivadelgat for Pulmonary Hypertension Associated with Interstitial Lung Disease
去年
FDA Grants Breakthrough Therapy Designation to Olverembatinib for Ph+ Leukemia Treatment
13天前
Roivant and Pulmovant to Present Phase 2 PHocus Data for Mosliciguat in PH-ILD at ERS 2026
去年
Advances in TKIs and Immunotherapy Shift Treatment Paradigm in Ph-Positive ALL
去年
Ponatinib Plus Chemotherapy Shows Promise in Philadelphia Chromosome-Positive ALL
去年
FDA Approves Asciminib (Scemblix) for Newly Diagnosed Philadelphia Chromosome-Positive CML
第 1 页,共 1978 页
上一页
下一页